m+Medelevator.RU
← Поиск публикаций
Journal of diabetes science and technology · 2026

Continuous Glucose Monitoring-Derived Glucose Metrics Over Time in Physically Active Adults Without Diabetes Using a Commercial Continuous Glucose Monitoring Application.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Skroce Kristina, Zignoli Andrea, Turner Lauren V, Lipman David J, Riddell Michael C, Zisser Howard C

Аннотация

BACKGROUND: To describe changes in continuous glucose monitoring (CGM)-derived glucose metrics of healthy and physically active participants with mild dysglycemia at baseline (>5% time with glucose levels outside of 70-140 mg/dL) who wore a real-time CGM device (GSB, Glucose Sport Biosensor) integrated with a smartphone mobile application over an eight-week period (four GSB wear periods).

METHODS: Two hundred twenty-five participants (51 females and 174 males) aged 45.0 ± 10.1 years with body mass index 23.4 ± 3.9 kg/m2 with suboptimal time in tight range (TITR) (ie, <95%) wore a GSB for approximately eight weeks. Linear mixed-effects models (LMEMs) were used to compare the cumulative time in different glycemic zones (% time below range [TBR, <70 mg/dL]; % TITR [70-140 mg/dL]; % time above range [TAR, >140 mg/dL]) with respect to each GSB wear time.

RESULTS: Linear-mixed effects model analysis returned significant effects of sensor on TITR and TBR across four wear periods (both P < .001), with inter-individual variability in baseline values and response slopes. Each day of sensor wear increased TITR by 0.59% (95% confidence interval [CI]: 0.50, 0.69, P < 0.001) and reduced TBR (-0.42 %, 95% CI: -0.50, -0.35, P <.001) and TAR (-0.17 %, 95% CI: -0.24, -0.10, P < .001), with small sensor-dependent differences in daily improvements.

CONCLUSIONS: These findings indicate both cumulative and day-to-day gains in glucose control with repeated sensor use for individuals with a TITR <95%. Indeed, CGM use coincided with short-term improvements in glucose metrics. Future studies should directly measure lifestyle behaviors to determine which factors may contribute to improvements in glycemia.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты